Massachusetts General Hospital

Running trials

• Not yet recruiting

  Adiposity Distribution in Acute Respiratory Failure

  NCT07019987· Source

• Not yet recruiting

  Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

  NCT07216859· Source

• Not yet recruiting

  Intervention to Reduce Implicit Bias in Pharmacies

  NCT06487351· Source

• Not yet recruiting

  An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)

  NCT07923526· Phase 2/3· Source

• Not yet recruiting

  Safety Study of XT-150 in Participants With ALS

  NCT06704347· Phase 1· Source

• Not yet recruiting

  Reducing Arterial Inflammation Using Eplerenone and Statins in HIV

  NCT07892664· Phase 2/3· Source

• Not yet recruiting

  Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

  NCT07265739· Phase 2· Source

• Not yet recruiting

  Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies

  NCT07240805· Source

• Not yet recruiting

  Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PC

  NCT07765836· Phase 2· Source

• Not yet recruiting

  Training on Systemic and Organ Spec. PM in PC

  NCT07768917· Source

• Not yet recruiting

  Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization

  NCT07569250· Source

• Not yet recruiting

  A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment

  NCT07926321· Phase 2· Source

• Recruiting

  Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

  NCT06791057· Source

• Not yet recruiting

  Feasibility and Acceptability of Amani

  NCT07648043· Phase 1/2· Source

• Not yet recruiting

  Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation

  NCT07729332· Phase 4· Source

• Not yet recruiting

  A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum

  NCT07569367· Source

• Recruiting

  Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

  NCT07665372· Source

• Not yet recruiting

  Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)

  NCT07923591· Phase 2· Source

• Not yet recruiting

  LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol A

  NCT07685028· Source

• Not yet recruiting

  A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

  NCT06458907· Source

• Not yet recruiting

  Inhaled Nitric Oxide in Severe Obesity

  NCT06675435· Source

• Not yet recruiting

  The Care for America's Aging Study

  NCT06021704· Source

• Not yet recruiting

  Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated Cirrhosis

  NCT07755059· Source

• Not yet recruiting

  Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

  NCT07520110· Phase 3· Source

• Enrolling by invitation

  The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

  NCT07688239· Phase 2· Source

• Recruiting

  A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

  NCT07701941· Phase 1/2· Source

• Not yet recruiting

  CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC

  NCT07077083· Phase 2· Source

• Recruiting

  The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression

  NCT07699445· Phase 4· Source

• Recruiting

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· Phase 3· Source

• Recruiting

  Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML

  NCT07355335· Phase 1· Source

• Not yet recruiting

  Developing Resiliency and Exercise Using AI-based Messaging

  NCT07225283· Source

• Not yet recruiting

  Remote Monitoring in Progressive Supranuclear Palsy (PSP)

  NCT04753320· Source

• Recruiting

  Time Restricted Eating (TRE) in Bipolar Disorder

  NCT07211217· Source

• Recruiting

  Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD

  NCT07010302· Phase 4· Source

• Recruiting

  Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

  NCT07569926· Phase 4· Source

• Not yet recruiting

  NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome

  NCT07278492· Phase 1· Source

• Recruiting

  An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

  NCT06996652· Phase 2· Source

• Recruiting

  Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?

  NCT07454733· Source

• Not yet recruiting

  Medically Tailored Meals to Reduce Ultra-processed Food Intake in Colorectal Cancer Survivors

  NCT07701707· Source

• Not yet recruiting

  ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma

  NCT07247097· Phase 2· Source

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Source

• Enrolling by invitation

  Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)

  NCT07496463· Phase 2· Source

• Recruiting

  A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer

  NCT07513311· Source

• Recruiting

  GBPDC: Gut-Brain in PD Consortium Master Protocol

  NCT07567794· Source

• Recruiting

  A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  NCT07719361· Phase 1· Source

• Recruiting

  Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

  NCT07005180· Phase 2· Source

• Recruiting

  Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

  NCT07751042· Phase 1/2· Source

• Enrolling by invitation

  Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission

  NCT07866872· Source

• Recruiting

  LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B

  NCT07600801· Source

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  NCT07644559· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer51 recruiting
• Colorectal cancer29 recruiting
• Ovarian cancer24 recruiting
• Prostate cancer20 recruiting
• Heart failure19 recruiting
• Childhood cancers18 recruiting
• Pancreatic cancer17 recruiting
• Melanoma16 recruiting
• Stroke16 recruiting
• ALS (motor neurone disease)14 recruiting
• Coronary artery disease14 recruiting
• Gastric and esophageal cancer14 recruiting
• Obesity14 recruiting
• Endometrial cancer13 recruiting
• Head and neck cancer13 recruiting
• High blood pressure13 recruiting
• Liver and biliary tract cancer13 recruiting
• Metastatic breast cancer13 recruiting
• Parkinson disease12 recruiting
• Triple-negative breast cancer12 recruiting
• Type 2 diabetes12 recruiting
• Alzheimer disease11 recruiting
• Depression11 recruiting
• Multiple myeloma11 recruiting
• Glioblastoma10 recruiting
• HIV9 recruiting
• Acute myeloid leukemia8 recruiting
• Bladder cancer8 recruiting
• Atrial fibrillation7 recruiting
• Cervical cancer7 recruiting
• Cystic fibrosis7 recruiting
• Pulmonary arterial hypertension7 recruiting
• Amyloidosis6 recruiting
• Chronic kidney disease6 recruiting
• Epilepsy6 recruiting
• Idiopathic pulmonary fibrosis6 recruiting
• Myeloproliferative neoplasms6 recruiting
• Sarcoma6 recruiting
• Crohn's disease5 recruiting
• Diffuse large B-cell lymphoma5 recruiting
• Mesothelioma5 recruiting
• Myelodysplastic syndromes5 recruiting
• Thyroid cancer5 recruiting
• Bipolar disorder4 recruiting
• Follicular lymphoma4 recruiting
• Kidney cancer4 recruiting
• Multiple sclerosis4 recruiting
• Neuromyelitis optica (NMOSD)4 recruiting
• Ulcerative colitis4 recruiting
• Chronic myeloid leukaemia3 recruiting
• COPD3 recruiting
• Lewy body dementia3 recruiting
• Lupus (SLE)3 recruiting
• Myasthenia gravis3 recruiting
• Rheumatoid arthritis3 recruiting
• Type 1 diabetes3 recruiting
• Asthma2 recruiting
• Autism2 recruiting
• Chronic lymphocytic leukaemia2 recruiting
• Fatty liver disease (MASLD/MASH)2 recruiting
• Frontotemporal dementia2 recruiting
• Mantle cell lymphoma2 recruiting
• Neuroendocrine tumours2 recruiting
• Sickle cell disease2 recruiting
• Systemic sclerosis (scleroderma)2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• ANCA-associated vasculitis1 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Hepatitis B1 recruiting
• Hodgkin lymphoma1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Long COVID and ME/CFS1 recruiting
• Osteoporosis1 recruiting
• Primary biliary cholangitis1 recruiting
• Retinitis pigmentosa1 recruiting
• Schizophrenia1 recruiting
• Thalassaemia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders

  NCT05974293· Phase 2· Source

• Withdrawn

  Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma

  NCT07283848· Phase 2· Source

• Completed

  Pilot Study of a Brain Health Program in Senior Centers

  NCT07424443· Source

• Completed

  Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care

  NCT07364825· Source

• Withdrawn

  Feasibility Study of LUM Imaging System for Pancreatic Cancer

  NCT04276909· Source

• Completed

  Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

  NCT06182241· Source

• Terminated

  An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)

  NCT06961344· Phase 2· Source

• Recruiting

  A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

  NCT06908928· Phase 1· Source

• Completed

  Data Collection for Echocardiography-Based Software Assessment

  NCT07126600· Source

• Completed

  Innovative Automated Insulin Delivery System for Type 2 Diabetes

  NCT06853990· Source

• Completed

  A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

  NCT06262113· Source

• Recruiting

  Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

  NCT06690398· Phase 3· Source

• Completed

  Investigating the Relationship Between Glycemia and Sleep in Adults With Cystic Fibrosis-Related Diabetes

  NCT06700889· Source

• Completed

  Sapphire 3 CTO Study

  NCT06358508· Source

• Completed

  Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening

  NCT06472869· Source

• Completed

  PACE CF, a 3-session Mind-body Pain Management Program for Adults With Cystic Fibrosis

  NCT06606457· Source

• Completed

  A Phase 2b Study of Zagociguat in Patients With MELAS

  NCT06402123· Phase 2· Source

• Recruiting

  PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

  NCT06445608· Source

• Completed

  CHW Intervention to Improve Nutrition Security of Patients With Hypertension

  NCT06358417· Source

• Withdrawn

  Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD)

  NCT04594616· Source

• Completed

  Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

  NCT06322342· Phase 2· Source

• Completed

  RECOVER-SLEEP: Platform Protocol

  NCT06404086· Phase 2· Source

• Completed

  RECOVER-ENERGIZE Platform Protocol

  NCT06404047· Source

• Completed

  Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy

  NCT06387186· Phase 1· Source

• Withdrawn

  Immunomodulatory Effects of PCSK9 Inhibition

  NCT05720156· Source

• Completed

  Supporting Our Caregivers In ADRD Learning (SOCIAL)

  NCT06276023· Source

• Completed

  Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

  NCT06273124· Source

• Completed

  A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors

  NCT06208124· Phase 1/2· Source

• Completed

  Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

  NCT06265532· Phase 1· Source

• Completed

  The T1D Parent Check-In: A Preventative Intervention

  NCT06160934· Source

• Completed

  Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

  NCT06004167· Source

• Terminated

  PRO1107 in Patients With Advanced Solid Tumors

  NCT06171789· Phase 1/2· Source

• Completed

  Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial

  NCT06089135· Source

• Completed

  Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

  NCT05934526· Phase 3· Source

• Completed

  Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

  NCT06234488· Source

• Completed

  Esophageal Cancer Multimodal Prehabilitation Study

  NCT06027515· Source

• Terminated

  Study of ALE.C04 in Patients With Head and Neck Cancer

  NCT06054477· Phase 1/2· Source

• Completed

  Dampening the Reproductive Axis With Continuous Kisspeptin

  NCT05971849· Phase 1· Source

• Completed

  Guideline Directed Medical Therapy in Patients With Heart Failure

  NCT06700213· Source

• Completed

  MASC: Reducing Stress for Caregivers

  NCT05847153· Source

• Completed

  Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

  NCT06060665· Phase 3· Source

• Completed

  Facilitators and Barriers to the Clinical Implementation of MR-001

  NCT06003790· Source

• Completed

  Phase 1 Study to Assess Safety and Efficacy of ANG003

  NCT06052293· Phase 1· Source

• Completed

  Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

  NCT05195918· Phase 1· Source

• Completed

  Health Outcomes of Parents With Cystic Fibrosis

  NCT05829694· Source

• Withdrawn

  Fulvestrant + Neratinib In Breast Cancer

  NCT04901299· Phase 2· Source

• Completed

  Conditionally Increased Output (CIO) Enhanced Ultrasound System

  NCT05792423· Source

• Terminated

  PR3-AAV Resilient Remission or PRRR

  NCT05376319· Phase 2· Source

• Completed

  A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

  NCT05864846· Phase 4· Source

• Completed

  TRAQinform Assessment of Immunotherapy Response

  NCT05819255· Source